Arş. Gör. MUHAMMET CENGİZ | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

Makaleler 6

1. Prognostic value of HER2 2 + expression in patients with TNBC receiving adjuvant capecitabine

Önder T., CENGİZ M., Koçoğlu S. S., Ateş Ö., YAZICI O., İNANÇ M., et al.

Clinical and Translational Oncology , cilt.27, sa.7, ss.3121-3129, 2025 (SCI-Expanded, Scopus)

2. The Role of Clinicopathological Features in Tyrosine Kinase Inhibitory Duration in EGFR Mutant Metastatic Non-Small Cell Lung Cancer

Dogan E., Firat S. T., CENGİZ M., BOZKURT O., İNANÇ M., ÖZKAN M.

Journal of Clinical Medicine , cilt.14, sa.4, 2025 (SCI-Expanded, Scopus)

3. Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer

BUĞDAY İ., İNANÇ M., ÖZKAN M., BOZKURT O., COŞAR R., FIRAT S. T., et al.

Anti-Cancer Drugs , cilt.36, 2025 (SCI-Expanded, Scopus)

4. Impact of Clinicopathological Features on Prognosis in KRAS Mutant Metastatic Colorectal Cancer

Dogan E., CENGİZ M., BOZKURT O., İNANÇ M., ÖZKAN M.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.35, sa.1, ss.12-16, 2025 (SCI-Expanded, Scopus)

Creative Commons License

5. Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study

YILDIRIM H. Ç., Kapar C., KÖKSAL B., Seyyar M., CAN ŞANCI P., GULIYEV M., et al.

JOURNAL OF CHEMOTHERAPY , cilt.37, sa.1, ss.69-75, 2025 (SCI-Expanded, Scopus)

6. The effect of albumin to alkaline phosphatase ratio on survival in patients with metastatic bone sarcomas

MUTLU E., BOZKURT O., İnanç M., Ozkan M., FIRAT S. T., Coşar R., et al.

Hitit medical journal (Online) , cilt.6, sa.1, ss.71-78, 2024 (TRDizin)

Metrikler

Yayın

6

Yayın (WoS)

5

Yayın (Scopus)

5

Açık Erişim

1